Your account's overdrawn buy non prescription flagyl Talisman shares have risen some 11 percent since the startof the month, as rumors swirled that an activist investor wasbuilding a position in the company. In the 12 months prior, thestock sagged 10 percent, despite a restructuring and asset saleprogram under a new management, as profits remained weak and itsNorth Sea operations faltered.
|